Company Filing History:
4 out of 1,744 
3 out of 319 
2 out of 14 
Years Active: 2018-2025
Title: Innovations of Laurence Legeai-Mallet in the Field of Chondrodysplasias
Introduction
Laurence Legeai-Mallet is a prominent inventor based in Paris, France. He has made significant contributions to the field of medical research, particularly in the treatment of FGFR3-related chondrodysplasias. With a total of four patents to his name, his work focuses on innovative therapeutic approaches for rare diseases.
Latest Patents
One of Laurence Legeai-Mallet's latest patents involves methods and pharmaceutical compositions for the treatment of FGFR3-related chondrodysplasias. FGFR3-related chondrodysplasias encompass a group of rare diseases, with achondroplasia being the most common type of dwarfism. This condition arises from a mutation that increases FGFR3 function, affecting various tissues, especially the cartilaginous growth plate and bone in the growing skeleton. In his research, the inventor purified (−)-epicatechin and demonstrated that treatment with (−)-epicatechin significantly increases the length of the Fgfr3 femurs compared to untreated Fgfr3 femurs, thereby improving the overall growth plate cartilage. This invention highlights the potential of (−)-epicatechin as a therapeutic agent for FGFR3-related chondrodysplasias.
Career Highlights
Throughout his career, Laurence Legeai-Mallet has worked with esteemed organizations such as the Institut National de la Santé et de la Recherche Médicale and Fondation Imagine. His dedication to advancing medical research has positioned him as a key figure in the field of genetic disorders.
Collaborations
Laurence has collaborated with notable colleagues, including Antonio Segura Carretero and Maria De La Luz Cadiz Gurrea. These partnerships have contributed to the success of his research and the development of innovative treatments.
Conclusion
Laurence Legeai-Mallet's work in the field of FGFR3-related chondrodysplasias exemplifies the impact of innovative research on rare diseases. His contributions continue to pave the way for new therapeutic approaches that can improve the lives of those affected by these conditions.